These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23382406)

  • 1. Prognostic significance of baseline heart rate and its interaction with beta-blocker use in resistant hypertension: a cohort study.
    Salles GF; Cardoso CR; Fonseca LL; Fiszman R; Muxfeldt ES
    Am J Hypertens; 2013 Feb; 26(2):218-26. PubMed ID: 23382406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study.
    Salles GF; Cardoso CR; Muxfeldt ES
    J Hypertens; 2009 May; 27(5):1094-101. PubMed ID: 19390353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of nocturnal blood pressure reduction in resistant hypertension.
    Muxfeldt ES; Cardoso CR; Salles GF
    Arch Intern Med; 2009 May; 169(9):874-80. PubMed ID: 19433699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.
    Salles GF; Cardoso CR; Pereira VS; Fiszman R; Muxfeldt ES
    J Hypertens; 2011 Oct; 29(10):2014-23. PubMed ID: 21873887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes.
    Takahama H; Yokoyama H; Kada A; Sekiguchi K; Fujino M; Funada A; Amaki M; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
    J Cardiol; 2013 Jan; 61(1):58-64. PubMed ID: 23165149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
    Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
    Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH.
    Böhm M; Reil JC; Danchin N; Thoenes M; Bramlage P; Volpe M
    J Hypertens; 2008 Jan; 26(1):18-25. PubMed ID: 18090536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
    Julius S; Palatini P; Kjeldsen SE; Zanchetti A; Weber MA; McInnes GT; Brunner HR; Mancia G; Schork MA; Hua TA; Holzhauer B; Zappe D; Majahalme S; Jamerson K; Koylan N
    Am J Cardiol; 2012 Mar; 109(5):685-92. PubMed ID: 22169130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients.
    Cice G; Di Benedetto A; D'Andrea A; D'Isa S; De Gregorio P; Marcelli D; Gatti E; Calabrò R
    J Nephrol; 2008; 21(5):704-12. PubMed ID: 18949725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    J Hypertens; 2010 Aug; 28(8):1715-23. PubMed ID: 20520577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study.
    Palatini P; Reboldi G; Beilin LJ; Eguchi K; Imai Y; Kario K; Ohkubo T; Pierdomenico SD; Saladini F; Schwartz JE; Wing L; Verdecchia P
    Int J Cardiol; 2013 Sep; 168(2):1490-5. PubMed ID: 23398827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations.
    Hansen TW; Thijs L; Boggia J; Li Y; Kikuya M; Björklund-Bodegård K; Richart T; Ohkubo T; Jeppesen J; Torp-Pedersen C; Lind L; Sandoya E; Imai Y; Wang J; Ibsen H; O'Brien E; Staessen JA;
    Hypertension; 2008 Aug; 52(2):229-35. PubMed ID: 18574073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect modification of aortic atheroma on the prognostic value of heart rate in hypertension.
    Courand PY; Milon H; Gustin MP; Froment A; Bricca G; Lantelme P
    J Hypertens; 2013 Mar; 31(3):484-91; discussion 491. PubMed ID: 23615211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-blockers modify the prognostic value of adiponectin in chronic heart failure.
    Van Berendoncks AM; Beckers P; Hoymans VY; Possemiers N; Coenen S; Elseviers MM; Vrints CJ; Conraads VM
    Int J Cardiol; 2011 Aug; 150(3):296-300. PubMed ID: 20488568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.